▲ Peaking
Business
Tempus AI Scoops Up Personalis For $1.5 Billion; But Shares Dive
Tempus AI has entered into a $1.5 billion agreement to acquire cancer test manufacturer Personalis, triggering a decline in both companies' share prices.